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Abstract 
Calponin is an actin-binding protein found in a variety of cells that is well known for its inhibition of 
actin-activated myosin ATPase. We hypothesize that calponin inhibits cellular secretion by two 
mechanisms. One mechanism is to prevent the cleavage of actin in the cytoskeleton, a gel-like mesh that 
acts as a physical barrier to vesicles travelling to the membrane, by gelsolin and other actin-severing 
proteins that cut paths for vesicles to travel. The other mechanism is to assist in the bundling and cross-
linking of actin, creating smaller pores in the mesh that are more difficult for the vesicles to move 
through.  This project conducted necessary background research, designed study and future 
experiments, and amplified pET and pCMV-HA vectors that will be used in the experiments. 
Background 
Calponin is a member of the family of actin-binding proteins. It was first identified in chicken gizzard 
smooth muscle by Takahashi et al. in 1986, and later indicated to inhibit contraction in those cells 
(Takahashi, Hiwada, & Kokubu, 1986; Takahashi, Hiwada, & Kokubu, 1988). Since then, calponin has 
been located in a number of cell types exhibiting a number of functions.  
Calponin is made up of three major domains. The first is a domain to which calponin has lent its 
name, the Calponin Homology (CH) domain. This domain is common amongst actin-binding proteins, 
and is the binding site for most of those proteins. Interestingly, calponin itself does not bind to actin this 
way, nor is it required for binding (Galkin, Orlova, Fattoum, Walsh, & Egelman, 2006). This is because the 
single CH domain calponin possesses is not strong enough to bind actin; typical actin-binding proteins 
may contain several CH domains. Instead, calponin’s primary binding site to actin is located in its second 
domain, called the “CLIK
23
 repeats” region because it contains a three-tandem repeat of 23 amino acids. 
Phosphorylation of specific residues in this domain prevents actin binding (Allen & Walsh, 1994).  
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The final calponin domain is known as the variable region, located at the very end of the c-terminus 
(See Figure 2). Variations in this region give rise to different isoforms of calponin; there are three distinct 
calponin isoforms in all, named h1, h2, and h3-calponin (Strasser, Gimona, Moessler, Herzog, & Small, 
1993; Applegate, Feng, Green, & Taubman, 1994). Differences in length and amino acid sequence of the 
variable region give the isoforms’ distinct isoelectric points: h1-calponin is basic, h2-calponin is neutral, 
and h3-calponin is acidic. Because the calponin isoforms differ only in this small portion of their 
sequence, they have nearly identical structures. The structure similarity between them has caused the 
proposed functions any of the isoforms to be largely considered interchangeable with either of the 
others. 
Calponin’s function in 
smooth muscle cells has 
been studied much more 
extensively than its 
functions in other cells. In 
smooth muscle cells, 
Figure 2 – The comparative lengths and sequences of the variable region (in gray) of h1, 
h2, and h3-calponin. (Wu & Jin, 2008). 
Figure 1 – The structure of calponin, including the CH domain, the actin-binding CLIK
23
 repeats domain, and a secondary 
actin-binding site (ABS). Not shown is the variable region, located at the far c-terminal end (Rozenblum & Gimona, 2008).  
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contraction is completed through what is known as the sliding filament model. Similar to contraction in 
skeletal muscles, smooth muscle contraction involves the phosphorylation and subsequent binding of a 
myosin to a high-affinity site on actin (this process is Ca
2+
 dependant). Normally, this process activates 
the actin-dependent myosin ATPase, which would hydrolyze an ATP to cause myosin to rotate its 
“head”, forcing actin to slide along the filament and shorten the muscle (i.e. contract). 
Calponin’s mechanism of action in smooth muscle, however, is still not fully understood. It has been 
shown that calponin binds to actin in vitro, and inhibits activation of actin-dependent myosin ATPase 
(EL-Mezgueldi & Marston, 1996; Winder, Allen, Clément-Chomienne, & Walsh, 1998). Based on these 
two major factors and others, it is commonly accepted that calponin binds to actin filaments in 
contractile regions of smooth muscle cells and prevents 
the activity of myosin’s ATPase by blocking the required 
ATPase activation site on actin. This inhibition prevents a 
vital step in the sliding of actin along myosin, thereby 
preventing muscular contraction.  
 Calponin localizes not only to actin found in 
contractile machinery, but also to actin in the cellular 
cytoskeleton (North, Gimona, & Small, 1994). The actin 
cytoskeleton’s main role is to provide support and 
stability to a cell, similar to the way our skeletons help us 
maintain our shape. It is made up of a tight mesh of actin 
microfilaments that are bound together by cross-linker 
proteins. The microfilaments can contract with the help 
of motor proteins such as myosin. Controlled 
Figure 3 – The creeping cell model for cell motility. As 
new actin polymerizes on the leading edge, the 
trailing edge’s actin contracts. 
<http://www.biolsci.org/v03/p0303/ijbsv03p0303g0
1.jpg> 
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cytoskeleton contraction and expansion via actin 
polymerization allows for mobility of specific regions in 
cells. This regional mobility can be used for a myriad of 
cellular functions; some examples include cell motility by 
expanding one end of a cell and contracting the other (See 
Figure 3), or cytokinesis by contracting a ring of actin 
microfilaments around the cytoplasm to bisect a dividing 
cell (See Figure 4).  
Calponin has been shown to inhibit actin-myosin 
mediated activity in the cytoskeleton as well as contractile 
machinery. Over-expressing h1-calponin in smooth muscle cells decreased their cell proliferation rate 
(Hossain, Hwang, Huang, Sasaki, & Jin, 2003). Additionally, h1-calponin knockout mice showed early 
onset of cartilage formation and ossification, and exhibited accelerated bone fracture repair consistent 
with an increased rate of cell proliferation (Yoshikawa, et al., 1998). 
Calponin appears to have a role in stabilizing the actin cytoskeleton. This was demonstrated by an 
increased resistance of actin to cytochalasin-B, a fungal metabolite that binds to actin and prevents 
polymerization, in NIH 3T3 fibroblast cells forced-expressing h2-calponin (Hossain, Crish, Eckert, Lin, & 
Jin, 2005). It has been shown in vitro cross-link and bundle actin filaments (Leinweber, Tang, Stafford, & 
Chalovich, 1999). This stabilization may be facilitated by another protein, however. A positive 
correlation has been seen between h2-calponin expression and tropomyosin expression. Tropomyosin is 
another actin-binding protein that regulates the interaction between actin and myosin in muscle cells. 
Like calponin, tropomyosin also binds tightly to actin and increases the polymerization rate of actin 
monomers in vitro (Wen, Kuang, & Rubenstein, 2000). Tropomyosin, however, has also been shown to 
Figure 4 – A cell undergoing cytokinesis. The 
contractile ring is made up of actin microfilaments. 
<https://eapbiofield.wikispaces.com/file/view/cyt
okinesis.gif> 
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increase stability of actin filaments directly (Warren, Lin, Wamboldt, & Lin, 1994; Broschat, Weber, & 
Burgess, 1989). H2-Calponin and tropomyosin may cooperatively stabilize actin filaments in the 
cytoskeleton, a relationship that is supported by the simultaneous decrease of endogenous tropomyosin 
and cell motility in h2-calponin deficient macrophage cells (Huang, Hossain, Wu, Parai, Pope, & Jin, 
2008). 
Introduction 
The cytoskeleton has long been assumed to play a significant role in the regulation of vesicle 
transport and exocytosis during the process of cellular secretion, though little is known about the 
process. Vesicles that must travel a short distance do so via diffusion. Vesicles required to travel long 
distances, however, require the assistance of motor proteins such as myosin that transport the vesicle 
to its destination. The motor protein binds to the cytoskeleton and utilizes it as a track, analogous to a 
shipping truck carrying cargo along a highway. 
Calponin’s inhibition of actin-activated myosin ATPase may play a role inhibiting secretion. It could 
prevent certain vesicles from being able to reach their destinations by disabling their motor protein. 
Myosin has not been strongly linked to this type of transport, however, and most motor proteins utilize 
microtubules, not actin filaments, as tracks to transport vesicles through the cell (Phelps, Foraker, & 
Swaan, 2003). Calponin cannot bind to tubilin, the main component of microtubules. Therefore, it is very 
unlikely to affect motor protein-mediated transport of vesicles very strongly. 
Regardless of the method of transport, the actin cytoskeleton has been shown to serve as a physical 
barrier to secretion (Aunis & Bader, 1988). During their journey to the cellular membrane, vesicles must 
pass through the actin cytoskeleton. The actin cytoskeleton is made up of a tight weave of cross-linked 
actin microfilaments. We believe that this weave creates pores of varying size that vesicles may have to 
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navigate through in order to pass through the actin cytoskeleton. This process is similar to the method 
by which polyacrylamide gels are used to size-separate molecules. 
Disruption of the actin cytoskeleton appears to positively affect the rate of secretion in cells. 
Latrunculin-B is a toxin that binds to actin and prevents polymerization of the actin monomers. Use of 
latrunculin-B to disrupt the actin cytoskeleton increased the average velocity of large vesicles in 
endothelial cells (Manneville, Etienne-Manneville, Skehel, Carter, Ogden, & Ferenczi, 2003). The use of 
the toxin also significantly decreased the overall run length of those vesicle. This suggests that the toxin 
likely created a cytoskeleton with a looser weave that was easier for the vesicle to navigate. 
Similar disruption effects may occur naturally in vivo. Gelsolin, a member of the family of actin-
severing proteins, cuts actin with a very high efficiency and appears to be associated with secretion. 
Knockdown of gelsolin decreased glucose-initiated insulin secretion in MIN6 B1 -cells, while over-
expressing gelsolin in those cells increased secretion (Tomas, Yermen, Min, Pessin, & Halban, 2006). This 
suggests that actin-severing activity is a vital component of cellular secretion. It may be required to clear 
a path for vesicles to travel through in order to reach the membrane. 
Secretion Study – Model, Hypothesis, and Experiments 
From the data above, we have derived a model for vesicle secretion via the actin cytoskeleton. 
Vesicles arrive at the actin cytoskeleton, by diffusion or molecular proteins depending on the origin and 
destination of the vesicle. They then must pass through the actin cytoskeleton, navigating through the 
porous gel of cross-linked actin filaments. The actin-severing protein gelsolin is recruited to assist the 
vesicle by cleaving specific microfilaments, which provides a clearer path for vesicles to travel through. 
Once through the cytoskeleton, the vesicle merges with the membrane and expels its contents, thereby 
completing the process of secretion. 
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Based on this secretion model, it is our hypothesis that calponin inhibits cellular secretion. We 
predict that calponin has a two-fold effect in hindering this process, both of which are facilitated by 
calponin’s stabilizing effect of actin filaments. Calponin binds to actin in the cytoskeleton. There, it 
shields the actin microfilament from actin-severing proteins such as gelsolin and prevents its cleavage. 
Calponin also assists in bundling and possibly cross-linking actin microfilaments. This creates a tighter 
weave of actin with smaller pores. As a result, vesicles have a harder time passing through the actin 
cytoskeleton with bound calponin, because of the existence of small, uncleaved pores that are difficult 
to navigate through. This causes a decrease in average vesicle velocity and an increase in total run 
length because the vesicles must travel around pores that are now too small for them to pass through. 
Secretion slows as vesicles struggle to escape the cytoskeleton; it is possible even that vesicles become 
completely trapped by the actin cytoskeleton, preventing secretion all together. 
Our hypothesis is supported by a recent study in which Cnn2 (the gene that encodes h2-calponin) 
knockout RAW264.7 mouse macrophage cells showed a significant increase in phagocytotic activity 
(Huang, Hossain, Wu, Parai, Pope, & Jin, 2008) (Huang, Hossain, Wu, Parai, Pope, & Jin, 2008). Logically, 
if a depletion of h2-calponin in macrophages increases uptake of exogenous material, then over-
expression of h3-calponin resulting in decreased secretion in neuronal cells is also likely as their 
mechanisms, though reversed, are largely the same. 
We plan to test our hypothesis by monitoring secretion in neuronal cells that are hypo- and hyper- 
expressing h3-calponin. Over-expression of h3-calponin will be induced by transfection of neural cells 
with the pCMV-HA vector (See Figure 5) cloned with h3-calponin in the Multiple Cloning Site (MCS). This 
h3-calponin insert will be under the control of the powerful constitutive cytomegalovirus (CMV) 
promoter, which will greatly amplify h3-calponin expression in transfected cells.  H3-Calponin will also 
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be labeled with a hemagglutinin (HA) epitope tag. This 
tag can be detected using HA-TAG Polyclonal 
Antibodies for proper selection and analysis of 
transfected cells. 
Knockdown of h3-calponin in neural cells will likely 
be induced by RNA interference. dsRNA with sequence 
complementary to Cnn3 mRNA will be introduced into 
neural cells endogenously expressing h3-calponin. This 
dsRNA will be cleaved by a member of the RNAse III 
family, resulting in several small interfering RNA (siRNA) 
fragments. These fragments will be absorbed by the RISC complex, which will locate its complementary 
mRNA (Cnn3) and induce degradation of the mRNA. A potential problem with this method is the 
possible existence of sequence homology between genes (such as Cnn2 and Cnn3) that would result in 
undesired knockdown of other products. One workaround for this issue could be to create the siRNA 
from cDNA of the variable region of h3-calponin. This would ensure that the inhibition does not 
suppress the other calponin isoforms; however, homology with another unknown mRNA could still be 
possible. 
This study will measure secretion rate over time by monitoring levels of Human Growth Hormone 
(hGH) present in the cell medium across multiple time points. hGH is a protein naturally secreted by the 
pituitary gland, however we will use neural cells that do not endogenously express hGH. These cells will 
also be transfected with a vector for controlled hGH expression. One vector of choice would be the pCI-
neo Mammalian Expression Vector (Promega) that utilizes an inducible T7 promoter. 
Figure 5 – Simple representational map of the 
pCMV-HA vector. 
<http://www.clontech.com/products/detail.as
p?tabno=2&catalog_id=631604&page=all> 
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Secreted hGH levels in cell culture media will be measured in an ELISA assay using an anti-hGH 
antibody. Because the ELISA will be measuring hGH present outside the cell, the process does not 
require cell lysis and is non-destructive. Therefore, it can be performed repeatedly on a single culture. 
When the assay is applied continuously over time a rate of secretion can be established.  
These rates will be measured in the cells that have varying levels of calponin: cells over-expressing 
calponin, cells under-expressing calponin, and cells whose endogenous calponin expression is 
unchanged. Neural cells without transfected hGH, and a separate neural cell line with no endogenous 
h3-calponin expression would be used as a negative controls. So far, only the vector that will be used to 
over-express calponin has been created; no cells have yet been transfected. Based on our hypothesis, 
the rate of secretion will decrease as the presence of calponin increases. 
This project worked to design the experiments for this study and another calponin study as part of 
on-going calponin research at the University of Edinburgh. The scope of these studies is larger than any 
single project. Therefore, it was the goal of this project to research calponin, design study experiments, 
propose future studies, and complete as much preliminary lab work as time allowed. The result of the 
lab work was the amplification of pET and pCMV-HA vectors that will be used in the experiments. The 
pET vector (See Figure 6) is an E. coli based expression vector for controlled expression of a gene of 
interest through implementation of a T7 promoter and lacO 
repressor. 
  
Figure 6 – A simple representational map of the pET vector. 
<http://www.bio.davidson.edu/Courses/Molbio/MolStudents/spring2003/Caus
ey/pET.html > 
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Materials and Methods 
Amplification of pET, pCMV-HA, and GFP-Calponin Vectors 
Three vectors were amplified for the secretion experiments during the course of this project. For the 
calponin secretion study, three h3-calponin-containing vectors were obtained from an associate lab that 
had modified them for a previous study. The vectors consisted of a pET vector for controlled translation 
of h3-calponin in E coli, a GFP-Calponin vector for detection of h3-calponin, and a pCMV-HA vector for 
transfecting and over-expressing h3-calponin in neural cells. The steps of amplification are described 
below, beginning with the creation of calcium competent cells, the transformation of those cells with 
the vectors above, and finally preparation of the transformed cultures to extract purified vector. 
Creation of DH5α and XL-10 Gold Calcium Competent Cells 
Competent cells for later transformative use were created from stocks of DH5α and XL-10 Gold E coli 
cells obtained from a cell bank. Each stock was grown in a starter culture of 2mL LB broth, and then used 
to inoculate a 50mL flask of LB broth. The 50mL culture was incubated at 37°C for 1.5 to 2.5 hours to 
ensure log phase growth of the cells. The cells were transferred to a 50mL Falcon tube and incubated on 
ice for 10 minutes before being pelleted in a J-68 centrifuge at 6,000g for 15 minutes. The pellet was 
resuspended in 25mL of 100mM CaCl2 and incubated on ice for 15 minutes. The cells were pelleted 
again and then resuspended in 2mL of 100mM CaCl2. The suspension was stored at 4°C and used for one 
week before being discarded. 
Transformation of Calcium Competent Cells 
Vectors were used to transform cells for the purposes of amplification during this project. 1μL of the 
transforming vector was added to 100μL of competent cells, mixed, and then incubated on ice for 30 
minutes. After this time, the cells were heat-shocked in a 42°C heat block for exactly 90 seconds, and 
then returned to ice for one minute. 500μL of LB broth were added to the cells and then incubated at 
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37°C for 30 minutes. 20μL or 500μL were streaked onto each of two plates containing the antibiotic 
resistance conferred by the transforming vector (amp for pCMV-HA and pET, kan for GFP-calponin). 
Plates were then incubated at 37°C overnight.  
Midi-Prep of Transformed Culture 
Transformed cells containing vectors of interest were midi-prepped to yield pure and concentrated 
vectors. A single colony was picked from the 20μL selective plate and used to inoculate a 50mL flask of 
LB broth containing the appropriate antibiotic. The flask was then incubated at 37°C overnight with 
shaking. The QIAGEN Plasmid Midi Kit was used to extract the plasmid, and the basic procedure 
presented in the product handbook was followed. The culture cells were pelleted in a J-68 centrifuge at 
6,000g for 15 minutes, and then resuspended in 4mL of P1 resuspension buffer (that contained RNAse 
and was stored at 4°C). 4mL of P2 lysis buffer was added to the cells, mixing by inversion, and then 
incubated at room temperature for 5 minutes. 4mL of P3 neutralization buffer was added, mixing by 
inversion, and then incubated on ice for 15 minutes. The solution was centrifuged in a J-10 
ultracentrifuge at approximately 20,000g for 30 minutes and then again for 15 minutes, removing the 
plasmid-containing supernatant after each spin. 
A QIAGEN-tip 100 was equilibrated by gravity flow with 4mL of buffer QBT. The supernatant from 
the centrifugation was pulled through the tip by gravity flow, and then the tip washed with two 10mL 
lots of buffer QC. The plasmid was eluted and captured using buffer QF. The DNA was precipitated with 
3.5mL isopropanol and then centrifuged as before, this time discarding the supernatant. The pellet was 
washed and spun twice with 2mL ethanol, air-dried, and then resuspended in 50μL TE buffer. 
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Results 
Amplification of the pET, pCMV-HA, and GFP-Calponin vectors yielded ample product with which to 
analyze h3-calponin and over-express it in E coli and in mammalian neural cells. Unfortunately, there 
was not enough time to analyze the products. Thus, no figures have been created to verify these results. 
Successful transformation can be assumed, however, based on the growth of cells on the antibiotic 
selection plates and in culture flasks also containing antibiotic.  
Because of the lack of analysis, the amplified vectors may contain chemical (i.e.: ethanol), protein, or 
DNA-based contamination from incomplete purification of the extracted cultures. The products must be 
separated on an agarose gel to verify successful transformation and purification of the correct vector, to 
ensure that the vectors were not damaged and that unwanted DNA was not extracted along with the 
vector. DNA concentrations must be determined via spectrophotometry, both to gauge the relative 
output of the transformation/purification and to determine whether unwanted proteins are in the 
products. 
Discussion 
It has not yet been decided which cell line to use for the experiments. We know that we want to use 
a neural cell line that endogenously expresses h3-calponin but not human growth hormone. The 
decision has not been made due to funding issues; we want to determine if we can obtain, as a gift from 
another lab, neural cells that match our requirements. We will have little choice regarding which line we 
will be using if this is the case. Thus, it is pointless to choose a specific cell line for the experiments until 
we are closer to actually conducting them. Many neural cells express h3-calponin endogenously, 
however, so finding a suitable cell line should not be difficult. 
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Much of what is “known” about calponin is based on speculations and assumptions. This can be 
attributed to two major factors: the difficulty of studying calponin in vivo, and the lack of research 
regarding calponin’s isoforms. Very little evidence has been gathered about calponin from in vivo studies 
that can accurately and definitively pinpoint calponin’s roles in the cellular machinery. Additionally, 
most of what has been discerned about calponin has been from studies of h1-calponin and, to a lesser 
extent, h2-calponin; very little is known about h3-calponin and its functions. The uncertainty 
surrounding calponin allows increasingly hypothetical theories to be formulated and tested. The model 
that we propose is of this type, because so little is known about h3-calponin. We have assumed many 
aspects of calponin’s involvement in both secretion and the actin cytoskeleton based on studies with 
only partial or potential relevance to h3-calponin. 
Our study attempts to support or reject our hypothesis that h3-calponin inhibits secretion in neural 
cells that is derived from a model that implicates calponin to have a stabilizing effect on actin. The 
stabilizing effect that calponin may have on actin has significant implications relating to all cellular 
functions involving the actin cytoskeleton, including phagocytosis, secretion, cell motility, proliferation, 
and intracellular transport. We have chosen to study h3-calponin’s impact on the secretion of hGH in 
neural cells because it can be monitored easily using the hGH ELISA and will provide valuable insight into 
the validity of our proposed model. 
 Comparing the rate of hGH secretion in cells that are over, under, or normally expressing calponin 
will provide us with a correlation coefficient between calponin levels and secretion rate. Our model 
assumes that there will be a negative correlation between these two factors. That is, as h3-calponin 
levels increase in neural cells, their rate of hGH secretion will decrease, and vice versa. If the results of 
our study conclude that the correlation is indeed negative then our hypothesis, and by extension our 
model, will be supported.  
15 A Study of Calponin’s Role in Secretion 
 
 
If the RNAi mechanism failed to silence the expression of h3-calponin effectively, the results of the 
study would indicate a negative correlation between over-expression and endogenous expression of 
calponin and a no correlation between under-expression and endogenous expression of calponin. 
Further study to determine the effectiveness of the RNAi experiments would be required. If it turns out 
to be ineffective, then it can be assumed that the overall correlation between h3-calponin expression 
and secretion is negative. In this case, the hypothesis will still be supported, although much more 
weakly. 
Another possible result from the secretion study is a positive correlation between h3-calponin levels 
and hGH secretion. This result would reject our hypothesis outright, and would suggest that our model is 
fundamentally flawed. The flaw would in turn suggest that assuming the relevance of certain data that is 
vital to the validity of our model was a mistake. Many aspects of our model were created this way, and 
error in any of them could create this type of result. Regardless, a new model would have to be created 
that accounts for the positive correlation. 
Finally, the study could result in a lack of correlation, or the inability to determine if a correlation 
exists. In either of these cases, the results would be largely inconclusive towards the support or rejection 
of our hypothesis. This could imply that our model is mostly correct except for some small error that 
serves to skew our results, or that there is be a miss-estimation of the importance of h3-calponin in the 
proposed model. In this case, secretion could still function largely as described, but may not have an 
effect as grand as implied. 
Alternatively, a lack of correlation would be noticed if calponin was a part of a larger complex in 
which another member was a limiting factor. In this scenario, increasing calponin’s concentration in the 
cell would have no effect on the complex’s overall efficiency, and thus no effect on secretion. This would 
be despite calponin’s involvement in secretion regulation.  For example, if calponin must first bind to 
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another protein before it can bind actin, and this other protein is present in limited quantity, then 
increasing calponin’s concentration would serve no purpose. 
Due to the extreme complexity of cellular secretion, it will be difficult to determine all the 
implications of the results that we will obtain. This is because there is a multitude of explanations for 
whatever results we might get. Confounding effects, from proteins that are unaccounted for in the 
proposed model, could skew results significantly from what is expected. These effects could create 
correlations between calponin and cellular secretion that are not reliable in accepting or rejecting the 
hypothesis, such as the example described above. Thus, any support or rejection the secretion study 
results seem to give to our hypothesis will itself need to supported or rejected with further 
experimentation.  
Future Experiments 
As stated earlier, future experiments will need to be conducted about calponin and secretion no 
matter what the result of this study is. Obviously, the validity of many future experiments hinges on the 
results of this one; however, there is merit in certain experiments regardless. The story of cellular 
secretion is an immense novel, and this study will only reveal a page at best. 
Many factors (e.g. cell type, calponin isoform, environmental conditions) will have been highly 
controlled in order to create as understandable and unconfounded environment as possible. A logical 
next step will be to create studies which these controlled factors are altered in order to determine the 
extent of the validity of the proposed model. For example, the study should be repeated in other 
secretory cell types, such as B cells, or using a different calponin isoform, such as h2-calponin. The 
results of multiple studies combined will paint a much clearer picture than any single one alone. 
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In order to affirm the conclusions 
from this study, a more comprehensive 
study of h3-calponin and cellular 
secretion must be created. Establishing a 
Cre-Lox recombination model for 
calponin expression would be a good 
way to do this. In this model, two loxP 
sites are inserted into two introns that 
flank an exon of the Cnn3 gene. The 
addition of Cre recombinase initiates a 
deletion between and including the two loxP, knocking out expression of a functional h3-calponin 
protein (See Figure 7). Therefore, the Cre-Lox recombination model allows for completely inducible 
silencing of h3-calponin, and can be performed in vitro or in vivo. 
This model can be used to supplement the results of the proposed study by analyzing the effect of 
knocking out h3-calponin on hGH secretion in neural cells. Due to the model’s inducible nature, changes 
in cellular secretion rate can also be monitored before and after knockout. This information would prove 
to be valuable because statistical analysis of changes in the same population is more sensitive than 
analysis of changes between different populations. Thus, this model could detect a correlation between 
calponin and cellular secretion even if its effect was rather small. 
Additionally, a Cnn3 knockout mouse can be established using the Cre-Lox recombinase system for 
analysis of h3-calponin in vivo. A Cnn2 knockout model was created this way Huang et al. (Huang, 
Hossain, Wu, Parai, Pope, & Jin, 2008). The knockout mice could be examined for symptoms relating to 
secretion deficiency. This experiment would be more difficult to complete, however its results would be 
Figure 7 – A diagram depicting the Cre-Lox recombination mechanism. 
<http://www.healthcare.uiowa.edu/labs/Sigmund/Research%20Pages/
cre-loxp.htm 
18 A Study of Calponin’s Role in Secretion 
 
 
substantially more useful because they would provide insight into the function of h3-calponin on cellular 
secretion in the context of an entire organism rather than one cell type. Thus, any conclusions derived 
from the results would be much more valid than those made from in vitro studies would. 
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